乐观
$1.96
情景价格
$2.010
+0.094 (+4.69%)收盘时
Meiwu Technology Co Ltd is a holding company primarily engaged in functional skincare business. The Company operating through three segments. The Skincare Products & Service segment focuses on functional skincare formula development, skincare training services, and sales of skincare products. The Quality Food Products Platform segment primarily sells meal replacement drinks, compressed candies, and other food products to customers through an online platform. The Technical Services division mainly provides technical solutions to clients. The Company primarily operates in the domestic market.
Meiwu Technology Co Ltd (WNW) is not a good buy right now due to its extremely low current price of $1.95, a year-to-date change of -98.67%, and a very low RSI of 21.358 indicating oversold conditions. The stock has also experienced a significant decline of 98.78% over the past year, which raises concerns about its long-term viability.
情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

Meiwu Technology Announces 1-for-100 Reverse Stock Split

Meiwu Technology Announces Reverse Stock Split

Meiwu Technology Signs Share Purchase Agreement

Meiwu Technology Announces Direct Offering of 6.99 Million Shares

Meiwu Technology Announces $14 Million Direct Offering
Meiwu Technology Co Ltd is a holding company primarily engaged in functional skincare business. The Company operating through three segments. The Skincare Products & Service segment focuses on functional skincare formula development, skincare training services, and sales of skincare products. The Quality Food Products Platform segment primarily sells meal replacement drinks, compressed candies, and other food products to customers through an online platform. The Technical Services division mainly provides technical solutions to clients. The Company primarily operates in the domestic market. It operates in the Consumer Cyclicals sector (CATALOG AND MAIL- ORDER HOUSES industry).
Meiwu Technology Co Ltd (WNW) is not a good buy right now due to its extremely low current price of $1.95, a year-to-date change of -98.67%, and a very low RSI of 21.358 indicating oversold conditions. The stock has also experienced a significant decline of 98.78% over the past year, which raises concerns about its long-term viability.
暂无帖子
注册或登录后参与讨论本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。